PABINAFUSP ALFA
UNII TRF8S0U6ON

Substance Identification & Data

This profile provides standardized clinical and technical data for Pabinafusp Alfa, uniquely identified by the FDA Unique Ingredient Identifier (UNII) TRF8S0U6ON.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2140211-48-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

TRF8S0U6ON

CAS Registry Number

2140211-48-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

PABINAFUSP ALFA

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C170281

National Cancer Institute reference terminology for clinical and research data.

INN ID

10995

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Pabinafusp Alfa. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

PABINAFUSP ALFA

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN TRANSFERRIN RECEPTOR) (HUMAN-MUS MUSCULUS MONOCLONAL JR-141 .GAMMA.1-CHAIN) FUSION PROTEIN WITH PEPTIDE (SYNTHETIC 2-AMINO ACID LINKER) FUSION PROTEIN WITH HUMAN IDURONATE-2-SULFATASE, DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL JR-141 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HUMAN TRANSFERRIN RECEPTOR 1, TFR1) HUMANIZED MONOCLONAL ANTIBODY, FUSED WITH HUMAN IDURONATE-2-SULFATASE, GLYCOFORM ALFA:

PABINAFUSP ALFA [INN]

PABINAFUSP ALFA [JAN]

PABINAFUSP ALFA [WHO-DD]